Drugs / sulfalene
sulfalene
also known as
sulfamethoxypyrazine · AS-18908 · Kelfizine w · Longum · NSC-110433 · Sulfaleno · Sulfamethopyrazine · Sulfametopyrazine
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/31 trial | ||||||
| Phase 2/3 | NCT00510159 | Aug → Oct 2007 | urinary schistosomiasis | Dafra Pharma | Completed | No outcome recorded |
| Phase 31 trial · 1 missed | ||||||
| Phase 3 | NCT01054651 | Oct → Dec 2009 | Schistosoma mansoni infectious disease | Kenya Medical Research Institute | Completed | Missed primary |
Evidence & citations 10 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | sulfalene | “sulfalene (also known as sulfamethoxypyrazine; 250 mg)” PMID 20705516 ↗ Aug 2010 |
| Known as | AS-18908 | ChEMBL registry synonym — accepted as the source's own label CHEMBL1525826 ↗ |
| Known as | Kelfizine w | ChEMBL registry synonym — accepted as the source's own label CHEMBL1525826 ↗ |
| Known as | Longum | ChEMBL registry synonym — accepted as the source's own label CHEMBL1525826 ↗ |
| Known as | NSC-110433 | ChEMBL registry synonym — accepted as the source's own label CHEMBL1525826 ↗ |
| Known as | Sulfaleno | ChEMBL registry synonym — accepted as the source's own label CHEMBL1525826 ↗ |
| Known as | Sulfamethopyrazine | ChEMBL registry synonym — accepted as the source's own label CHEMBL1525826 ↗ |
| Known as | sulfamethoxypyrazine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00510159 ↗ |
| Known as | Sulfametopyrazine | ChEMBL registry synonym — accepted as the source's own label CHEMBL1525826 ↗ |
| Modality | Small molecule | — CHEMBL1525826 ↗ |